Skip to main content

Enzo Clincal Labs Joins Empire BlueCross BlueShield Network

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Health insurer Empire BlueCross BlueShield has included Enzo Clinical Labs in its provider network covering the metropolitan New York City area.

Coverage became effective Aug. 1, Enzo's parent firm, Enzo Biochem, and Empire BCBS jointly said today.

Coverage for Enzo's services is included in Empire PPO Plans, Empire EPO Plans, and Empire Indemnity Plans. The clinical lab, which is a wholly owned subsidiary of Enzo Biochem, provides clinical, cytology, and anatomic pathology services, as well as molecular, genetic, and ancillary testing, and customized test panels and profiles.

Empire BCBS is New York State's largest health insurer.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.